94 related articles for article (PubMed ID: 21129701)
1. [Requirements on evidence for system-level decision making regarding the adoption of medical services into the Statutory Health Insurance (SHI) catalogue].
Lange S; Thomas S
Z Evid Fortbild Qual Gesundhwes; 2010; 104(8-9):642-7. PubMed ID: 21129701
[TBL] [Abstract][Full Text] [Related]
2. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
3. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy?
Rizzo JD
Best Pract Res Clin Haematol; 2005; 18(3):439-48. PubMed ID: 15792918
[TBL] [Abstract][Full Text] [Related]
5. [Evidence-based scientific analysis of fundamental Medical Services of Statutory Health Insurance internal principle assessment].
Mayer ED; Boukamp K; Kruse F; Hansis ML; Windeler J
Z Arztl Fortbild Qualitatssich; 2001 Feb; 95(2):113-9. PubMed ID: 11268876
[TBL] [Abstract][Full Text] [Related]
6. The ethical basis of the precautionary principle in health care decision making.
ter Meulen RH
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):663-7. PubMed ID: 15993912
[TBL] [Abstract][Full Text] [Related]
7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
8. [Decision-analytical modelling of costs per QALY in the context of the German Social Law].
Rogowski WH; Landauer M; John J
Gesundheitswesen; 2009 Nov; 71(11):739-50. PubMed ID: 19551622
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations.
Manchikanti L
Pain Physician; 2008; 11(2):161-86. PubMed ID: 18354710
[TBL] [Abstract][Full Text] [Related]
10. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
11. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
Sayeed SA
Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
[TBL] [Abstract][Full Text] [Related]
12. ["Deficiencies in the mandatory health insurance system"--possibilities and limits of medical expert assessment].
Mayer ED; Boukamp K; Zink J; Simoes E; Schwoerer P
Gesundheitswesen; 2000 Oct; 62(10):538-46. PubMed ID: 11103565
[TBL] [Abstract][Full Text] [Related]
13. [Evidence-based medicine and public health law: statutory health insurance].
Dreher W
Z Arztl Fortbild Qualitatssich; 2004 Sep; 98(6):489-93. PubMed ID: 15527192
[TBL] [Abstract][Full Text] [Related]
14. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
15. Assessing the quality of healthcare provided to children.
Mangione-Smith R; McGlynn EA
Health Serv Res; 1998 Oct; 33(4 Pt 2):1059-90. PubMed ID: 9776949
[TBL] [Abstract][Full Text] [Related]
16. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
17. Evaluating medical effectiveness for the california health benefits review program.
Luft HS; Rappaport KM; Yelin EH; Aubry WM
Health Serv Res; 2006 Jun; 41(3 Pt 2):1007-26. PubMed ID: 16704669
[TBL] [Abstract][Full Text] [Related]
18. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
19. Use of economic evaluation in local health care decision-making in England: a qualitative investigation.
Eddama O; Coast J
Health Policy; 2009 Mar; 89(3):261-70. PubMed ID: 18657336
[TBL] [Abstract][Full Text] [Related]
20. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
Führlinger S
Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
